1. Introduction {#sec1}
===============

In 2011, approximately 20 million Americans were affected by thyroid disorders \[[@B1]\]. Individuals with diabetes are at greater risk for developing thyroid disorders and have a higher prevalence of thyroid disorders compared to the general population. Prevalence of thyroid disorders among individuals with diabetes ranges from 13%--32% compared to 5%--8% in the general population \[[@B2]--[@B5]\]. Although hypothyroidism is a common disorder among individuals with diabetes \[[@B2]--[@B5]\], hyperthyroidism is also prevalent and is estimated to be around 12% \[[@B6]\].

As thyroid hormones affect glucose metabolism \[[@B7]--[@B10]\], individuals with diabetes and hypothyroidism may suffer from frequent recurrent hypoglycemic episodes \[[@B11]\] and insulin resistance \[[@B12], [@B13]\]. Thyroid hormones also affect body weight, placing individuals with thyroid disorders at increased risk of obesity and negative consequences related to obesity \[[@B8], [@B12], [@B13]\]. Individuals with diabetes and hyperthyroidism may suffer from hyperglycemia possibly due to increased metabolism of insulin, increase in glucose absorption from gut, increase in endogenous glucose production, lipolysis resulted in hepatic gluconeogenesis, increase in growth hormones, glucagon and catecholamine levels \[[@B7], [@B9], [@B14]--[@B18]\].

Elevated risk of microvascular complications such as retinopathy and nephropathy among individuals with diabetes and subclinical hypothyroidism compared to individuals with diabetes and without subclinical hypothyroidism has been documented \[[@B19]--[@B22]\]. In addition, thyroid disorders may lead to macrovascular complications. In a recent study, subclinical hypothyroidism was associated with increased risk of cardiovascular mortality and morbidity specifically increased incidence of atrial fibrillation \[[@B23]\]. In addition, thyroid disorders cooccur with many common chronic conditions, for example, depression, arthritis, and asthma \[[@B24]--[@B28]\] which can further complicate the management of both diabetes and thyroid disorders.

The negative consequences of abnormally high or low levels of thyroid hormones on glycemic control, micro- and macrovascular complications can lead to greater economic burden as well. Among individuals with diabetes, macrovascular conditions are reported to be a major driver of healthcare expenditures \[[@B29]--[@B31]\]. However, studies that examine the excess economic burden measured by direct healthcare expenditures associated with thyroid disorders among individuals with diabetes are scarce. There is a need for studies in this area to better understand the drivers of greater healthcare expenditures among individuals with diabetes and thyroid disorders and develop strategies and programs to reduce the economic burden in this group. Therefore, the primary objective of the study is to provide cross-sectional estimates of additional healthcare expenditures associated with thyroid disorders among adults with diabetes by comparing them to those with diabetes and without thyroid disorders, using a nationally representative survey of households and families.

2. Methods {#sec2}
==========

2.1. Study Design {#sec2.1}
-----------------

This study utilized a cross-sectional design and compared healthcare expenditures among individuals with thyroid disorders and diabetes to individuals with diabetes without thyroid disorders.

### 2.1.1. Data Source {#sec2.1.1}

The Medical Expenditure Panel Survey (MEPS) data for the years 2007 and 2009 were used for this study. The MEPS is a set of large-scale surveys of families and individuals, their medical providers (doctors, hospitals, pharmacies, etc.), and employers across the United States of America (USA). The MEPS is cosponsored by the Agency for Healthcare Research and Quality (AHRQ) and the National Center for Health Statistics. The survey provides nationally representative estimates of healthcare use, expenditures, payment sources, health insurance coverage, health status, health conditions, and treatment for the civilian noninstitutionalized population of USA.

For the current study, we used household and medical conditions files of the MEPS. The household component collects person-level data on demographic characteristics, health conditions, health status, use of medical services, charges and payments, access to care, employment, health insurance coverage, and income for a period of two years. Medical conditions file provides information on medical conditions that were reported by the households. The medical conditions and procedures reported by the household component respondent are usually recorded by the interviewer as verbatim text, which is then coded by professional coders to fully specifiedInternational Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes, including medical condition and V codes \[[@B32], [@B33]\]. However, to preserve confidentiality, the MEPS data provide nearly all of the diagnosis condition codes only 3-digit ICD-9 CM codes. In addition, the MEPS data provide clinical classification codes, which are aggregated ICD-9-CM codes into clinically meaningful categories that group similar conditions. For the purpose of this study, we used both ICD-9 CM as well as clinical classification codes to identify the medical condition appropriately (see details of ICD-9CM and CCS crosswalk on: <http://meps.ahrq.gov/mepsweb/data_stats/download_data/pufs/h128/h128_icd9codes.shtml>).

We included data for the years 2007 and 2009 to gain sufficient sample size. As individuals are followed for two years, to avoid including repeated observations from the same individual, we selected alternate years.

2.2. Study Sample {#sec2.2}
-----------------

The study sample included adults, aged 21 years or older, and reported diabetes during the calendar years and alive during the calendar years. Diabetes was identified from clinical classification codes 49 and 50 ([Table 5](#tab5){ref-type="table"}). Detailed information on the crosswalk between ICD-9-CM codes and clinical classification codes is available elsewhere \[[@B32], [@B33]\]. The final study sample consisted of 4,490 individuals with diabetes, of whom 545 reported having thyroid disorders.

2.3. Measures {#sec2.3}
-------------

### 2.3.1. Dependent Variables {#sec2.3.1}

Healthcare Expenditures: Total and Type of ExpendituresWithin MEPS, healthcare services, which were paid by third-party payers and/or individuals themselves are defined as health expenditures and reported for each year. Expenditures are also distinguished by the type of expenditures, and aggregated by inpatient care; ambulatory care, provided in offices and hospital outpatient departments; care provided in emergency departments; prescribed medications, vision, dental, home health care, and others. Sources include direct payments from individuals, private insurance, Medicare, Medicaid, Veteran Affairs, other public insurance, workers\' compensation, and other sources \[[@B32], [@B33]\]. In current study, we classified the types of expenditures into: (1) inpatient; (2) emergency room; (3) outpatient; (4) prescription drugs; (5) other. Other expenditures included home health care, vision, dental, durable medical equipment, and ambulance services, orthopedic items, hearing devices, prostheses, bathroom aids, medical equipment, disposable supplies, alterations/modifications, and other miscellaneous items or services that were obtained, purchased, or rented during the year \[[@B32], [@B33]\]. Expenditures in 2007 were converted to 2009 dollars using the annual consumer price index for medical care services available from the bureau of labor statistics \[[@B34]\]. As expenditures data were skewed to the right, we transformed expenditures to natural logarithmic scale and we used logged expenditures as dependent variables in regression analysis.

Key Independent Variable: Presence of Thyroid DisordersThyroid disorders were identified using clinical classification code of 48, which represented all thyroid disorders such as acquired hypothyroidism (ICD-9-CM code −244), thyrotoxicosis (ICD-9-CM code −242), thyroiditis (ICD-9-CM code −245), and other disorders of thyroid (ICD-9-CM code −246) \[[@B35]\]. We created a dummy variable for presence of thyroid disorder for the purpose of analysis.

### 2.3.2. Other Independent Variables {#sec2.3.2}

Demographic variables included gender (women, men), categories of age in years (21--49, 50--64, and 65 and +), race/ethnicity (White, African American, Latino, and other), marital status (married, widowed, separated/divorced, and never married), and area of residence (metro and nonmetro). Socioeconomic characteristics were categorized by education (less than high school, high school, and above high school) and poverty status. The poverty status variable was defined poor (less than 100% federal poverty line), near poor (100% to less than 200%), middle income (200% to less than 400%), and high income (greater than or equal to 400%) available from MEPS represented family income in relation to the federal poverty line (based on family size and composition).

Health status was measured with widely used standard scales of perceived physical and mental health. Perceived physical and mental health status were categorized into excellent/very good, good, and fair/poor. Body mass index categories (BMI---normal or underweight, overweight, and obese), current smoking (yes/no), and vigorous physical activity at least 3 times/week (yes/no) represented lifestyle risk factors. Healthcare expenditures are often influenced by the presence of chronic physical conditions such as arthritis, chronic obstructive pulmonary disease (COPD), gastroesophageal reflux disease (GERD), other endocrine disease, and osteoporosis and mental health conditions such as depression and anxiety \[[@B31], [@B36]--[@B43]\]. Therefore, we also included the total number of cooccurring chronic conditions as one of the independent variables. For details of conditions and codes, please see [Table 5](#tab5){ref-type="table"}.

Macrovascular Comorbid ConditionsTo understand the association between diabetes complications and expenditures, we included macrovascular comorbid conditions as defined by Fu and colleagues \[[@B31]\] as one of the independent variables. The macrovascular comorbid conditions were defined using clinical classification codes and appropriate ICD-9 CM 3-digit codes, which included codes for cardiovascular disease (ischemic heart disease, congestive heart failure, aortic/visceral/peripheral aneurysms, visceral atherosclerosis, and peripheral vascular disease) and cerebrovascular disease (strokes and transient ischemic attacks).

2.4. Statistical Techniques {#sec2.4}
---------------------------

To test unadjusted differences in logged expenditures, ordinary least square regressions were used to estimate the incremental expenditures associated with thyroid disorders among individuals with diabetes. Effect estimates for continuous independent variables on the log of annual expenditures can be interpreted as percentage change for each unit of change in the independent variable. The effect of categorical variables in terms of percentage of expenditures can be estimated by exponentiating the regression coefficients of dummy variables and subtracting one (i.e., percent change = *e* ^*β*^ − 1) \[[@B42]\]. Therefore, in tables, we also present percent change in expenditures in addition to parameter estimates.

To understand the association between thyroid disorders expenditures among individuals with diabetes, we conducted four different regression models in which independent variables were entered in blocks. In Model 1, we controlled for age, gender and race/ethnicity. In Model 2, we adjusted for other demographic, socioeconomic, and life-style factors in addition to variables used in Model 1. In Model 3, in addition to the variables used in Model 2, we included number of cooccurring chronic conditions. In Model 4, we controlled for the presence of macrovascular comorbid conditions, in addition to all other variables included in Model 3. All analyses account for complex survey design of the MEPS and statistical testing was carried out with survey procedures in SAS 9.2.

3. Results {#sec3}
==========

3.1. Description of the Study Sample {#sec3.1}
------------------------------------

In our study sample, 12% (*N* = 545) individuals reported having cooccurring thyroid disorders. The demographics and socio-economic characteristics, access to care, health status, and personal health practices of individuals with diabetes with or without thyroid disorders are presented in [Table 1](#tab1){ref-type="table"}.

Among individuals with diabetes, gender, age, race/ethnicity, marital status, poverty status, health insurance, BMI, smoking status, and physical activity were significantly different between individuals with and without thyroid disorders. For example, a significantly higher proportion of women (20%) than men (7%) reported having thyroid disorders. Similarly, a significantly higher proportion of elderly who were 65 years or older (17.8%) reported having thyroid disorders compared to young adults in the age group 21--50 years (10.1%). Compared to African Americans (8.6%), a significantly higher proportion of Whites reported having thyroid disorders (16.3%). Regarding lifestyle risk factors, a lower proportion of smokers (10.5%) reported having thyroid disorders compared to nonsmokers (15%). Individuals who performed moderate-to-vigorous physical activity at least three times a week had lower rates of thyroid disorders (12.3%) compared to individuals who did not perform moderate-to-vigorous physical activity at least three times a week (15%).

We examined the prevalence of cooccurring chronic and macrovascular comorbid conditions ([Table 2](#tab2){ref-type="table"}). Among individuals with diabetes, those with thyroid disorders reported significantly higher rates of cooccurring chronic conditions and macrovascular comorbid conditions compared to their counterparts without thyroid disorders. For example, 39.5% of those with thyroid disorders reported the presence of any macrovascular comorbid conditions compared to 30.6% of individuals with diabetes and without thyroid disorders. Similarly, 35.8% of those with thyroid disorders reported heart disease compared to 28% among those with diabetes and without thyroid disorders.

In terms of number chronic conditions, 14.6% of those with thyroid disorders reported 5 or more conditions compared to 6.7% among those with diabetes and without thyroid disorders (data not shown in tabular form). In addition, individuals with thyroid disorders had significantly greater number of chronic physical and mental conditions compared to individuals without thyroid disorders.

3.2. Healthcare Expenditures {#sec3.2}
----------------------------

Among individuals with diabetes, comparisons of average total, inpatient, emergency room, outpatient, prescription drug, and other expenditures for those with and without thyroid disorders are presented in [Table 3](#tab3){ref-type="table"}. Significant group differences in expenditures were tested using log-transformed expenditures using an OLS regression in which the presence of thyroid disorders was the independent variable. Individuals with diabetes and thyroid disorders had significantly greater total healthcare expenditures than those without thyroid disorders (\$15,182 versus \$11,093, *P* \< 0.001). Using OLS on logged dollars, with only the presence of thyroid disorders as the independent variable, we found that among individuals with diabetes, presence of thyroid disorders was associated with 64.4% greater total expenditures compared to those without thyroid disorders.

With respect to types of expenditures, similar patterns were observed for outpatient, prescription drug, and other expenditures with presence of thyroid disorders among individuals with diabetes. However, the percent increase associated with thyroid disorders varied from as high as 170.7% for other expenditures to as low as 18.6% for emergency room expenditures.

[Table 4](#tab4){ref-type="table"} summarizes the parameter estimates, standard errors and *P* values of parameter estimates from separate OLS regressions on logged values of total and types of expenditures among individuals with diabetes with and without thyroid disorders. We also present percent change in expenditures associated with presence of thyroid disorders (last column of [Table 4](#tab4){ref-type="table"}). In the first model, in addition to presence/absence of thyroid disorders, we also included demographic (sex, age, and race/ethnicity). After controlling for these variables, the association between presence of between thyroid disorders and total healthcare expenditures remained significant. However, presence of thyroid disorders was associated with 43.8% greater total expenditures compared to those without thyroid disorders. When additional demographic factors (marital status, area of residence), economic factors (education, family poverty status), access to care factors (health insurance), lifestyle risk factors (smoking, physical activity), and health status factors (perceived mental and physical health) were controlled in Model 2, those with thyroid disorders had 34.3% greater total expenditures compared to those without thyroid disorders.

When cooccurring chronic conditions were entered into the model, those with thyroid disorders had 23.7% greater total expenditures compared to those without thyroid disorders. In the final model, when macrovascular comorbid conditions were included, the association between presence of thyroid disorders and total expenditures remained highly significant (beta = 0.19 which translated to 21.4% change in expenditures, *P* \< .001).

When examined by type of expenditures, however, for emergency-room-related expenditures, the presence of thyroid disorders was non-significant with the addition of chronic cooccurring conditions in Model 3. In the addition, the presence of thyroid disorders was inversely associated with emergency room expenditures with addition of macrovascular comorbid conditions in Model 4.

4. Discussion {#sec4}
=============

The current paper estimated incremental healthcare expenditures associated with thyroid disorders among individuals with diabetes. Individuals with diabetes and thyroid disorders had greater healthcare expenditures compared to individuals with diabetes without thyroid disorders, even after adjusting for demographic, economic, lifestyle risk factors, health status, number of cooccurring chronic conditions, and macrovascular comorbid conditions. Our estimates can be considered as an underestimate of the true economic burden because we did not include productivity lost due to missed work days and disability days due to thyroid disorders. Our exploratory analysis suggested that employed individuals with diabetes and thyroid disorders had greater number of work-loss days compared to employed individuals without thyroid disorders and diabetes. These findings indicate that the economic burden among individuals with thyroid disorders may even be greater than suggested by our estimates.

There are plausible reasons as to why direct healthcare expenditures may be greater for those with thyroid disorders and diabetes compared to individuals with no thyroid disorders and diabetes. For example, different types of thyroid diseases and management of thyroid disorders (i.e., thyroidectomy or radioiodine or medical therapy) may increase the direct healthcare expenditures because these procedures can be very resource-intensive \[[@B44]\]. Future research needs to examine the contribution of specific procedures in thyroid management to the economic burden of individuals with thyroid disorders and diabetes.

A closer examination of factors explaining the incremental direct healthcare expenditures associated with thyroid disorders revealed that nonmodifiable risk factors such as age, gender, and race/ethnicity explained 29.7% the incremental expenditures. After adjustment of other demographic and socioeconomic characteristics, access to care, lifestyle risk factors, perceived physical health, and perceived mental health, the presence of thyroid disorders was associated with nearly one-fifth (18.7%) greater total expenditures. These findings suggest that lifestyle risk factors such as smoking, obesity, and physical activity can be modified to reduce economic burden of thyroid disorders among individuals with diabetes.

Approximately one-fifth of incremental (21.6%) expenditures were explained by cooccurring chronic conditions. This is not surprising given that three-quarters of individuals with diabetes and thyroid disorders reported cooccurring conditions such as arthritis, depression cancer, and others compared to approximately one-half individuals with diabetes without thyroid disorders. Our findings suggest high comorbidity burden among individuals with thyroid disorders and diabetes. In addition, these findings highlight the need for providers to focus on comanagement of thyroid disorders, diabetes, and other cooccurring chronic conditions to reduce the economic burden of these individuals.

In terms of types of expenditures, it is interesting to note that there was no significant association between thyroid disorders and emergency room expenditures when controlled for chronic cooccurring condition. When macrovascular comorbid conditions were additionally entered into the model, the association was negative. Individuals with thyroid disorders had 2% lower expenditures compared to those without thyroid disorders. These findings suggest that excess emergency room expenditures due to thyroid disorders may be driven by cooccurring chronic conditions macrovascular comorbid conditions. It is also well documented that emergency room visits are associated with a greater number of chronic conditions and/or macrovascular comorbid conditions \[[@B45]--[@B47]\].

Our study findings have implications for healthcare management strategies for individuals with diabetes. With the growing economic burden of diabetes, healthcare management needs to focus on reducing excess economic burden associated with thyroid disorders among individuals with diabetes. These steps may include early detection and treatment of thyroid disorders. However, there is no systematic approach to screening for thyroid disorders among individuals with type 2 diabetes. Although ADA suggests for screening for thyroid disease at the time of diagnosis of type 2 diabetes \[[@B48]\], screening practices vary widely and pragmatic guidelines are lacking \[[@B49]\]. Our findings highlight the need for developing guidelines in terms of frequency and target population such as women and the elderly for thyroid screening among individuals with diabetes \[[@B48]\]. Furthermore, future studies need to evaluate cost effectiveness of routine thyroid screening among individuals with diabetes.

Our study had many strengths and some limitation. The strengths of our study include nationally representative study of adults with diabetes, large sample size, comprehensive list of variables that can influence expenditures such as cooccurring chronic conditions, health status, and capturing health care expenditures from a variety of sources. There are some limitations also. In MEPS, data on medical conditions and utilization are self-reported and may not be accurate. However, validation of chronic conditions against provider reports suggested that households tended to be accurate for conditions that affect daily life (e.g., diabetes, sensitivity 92.1%; thyroid disorders, sensitivity 85%) \[[@B50]\]. It has been reported that MEPS household respondents accurately reported inpatient hospitalizations but underreport emergency room and outpatient visits. However, such underreporting did not affect behavioral analyses \[[@B51]\]. Severity and duration information for diabetes, thyroid disorders, surgical procedures for thyroid disorders, and other conditions was not available; these may have further narrowed the incremental expenditures associated with thyroid disorders. However, the current study controlled for perceived health status and perceived mental health status. Although steps were taken by the MEPS designers to minimize recall bias (diaries and extensive probes to enhance recall), many variables were self-reported and subject to recall bias. In addition, information of microvascular complications may provide insight nto initial economic burden associated with those conditions in individuals with thyroid disorders. Finally, as our study used a cross-sectional design, therefore, we cannot establish causality.

5. Conclusion {#sec5}
=============

In conclusion, our study may be the first study to use a nationally representative survey to report that thyroid disorders were associated with higher healthcare expenditures among individuals with diabetes. Presence of cooccurring chronic conditions was one of the drivers of economic burden in these individuals. Our findings highlight the importance of comanagement of diabetes, thyroid disorders, and other chronic conditions. Future research need to focus on feasibility and cost effectiveness of routine thyroid screening among individuals with diabetes.
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###### 

Description of sample characteristics of individuals with diabetes by the presence of thyroid disorders from the Medical Expenditure Panel Survey, 2007 and 2009.

                               Total sample   No thyroid   Thyroid   Sig.                
  ---------------------------- -------------- ------------ --------- ------ ----- ------ -----
  Sex                                                                                     
   Female                      2,519          55.0         2,090     79.7   429   20.3   ∗∗∗
   Male                        1,971          45.0         1,855     93.0   116   7.0    
  Age                                                                                     
   21--50 years                1,001          20.5         924       89.9   77    10.1   ∗∗∗
   51--64 years                1,741          38.2         1,548     88.2   193   11.8   
   65 years or older           1,748          41.2         1,473     82.2   275   17.8   
  Race/ethnicity                                                                          
   White                       2,079          66.1         1,739     83.7   340   16.3   ∗∗∗
   African American            1,037          14.4         956       91.4   81    8.6    
   Latino                      1,023          12.7         927       89.4   96    10.6   
   Other                       351            6.7          323       91.4   28    8.6    
  Marital status                                                                          
   Married                     2,550          59.4         2,280     87.5   270   12.5   ∗∗∗
   Widowed                     696            14.9         567       79.0   129   21.0   
  Separated/divorced           799            16.9         703       87.5   96    12.5   
   Never married               445            8.8          395       86.0   50    14.0    
  Metro                                                                                   
   Metro                       3,627          80.4         3,192     86.1   435   13.9    
   Nonmetro                    863            19.6         753       86.1   110   13.9    
  Education                                                                               
   Less than high school       1,465          24.3         1,288     85.4   177   14.6    
   High school                 1,418          34.2         1,241     85.6   177   14.4    
   Above high school           1,565          41.5         1,379     86.9   186   13.1    
  Poverty status                                                                          
   Poor                        875            13.9         782       89.1   93    10.9   ∗∗
   Near poor                   1,121          21.5         976       82.8   145   17.2   
   Middle income               1,321          30.2         1,145     84.7   176   15.3   
   High income                 1,173          34.4         1,042     88.1   131   11.9   
  Health insurance                                                                        
   Private                     2,346          60.6         2,066     86.8   280   13.2   ∗∗
   Public                      1,706          32.1         1,472     83.4   234   16.6   
   Uninsured                   438            7.3          407       92.0   31    8.0    
  Body mass index categories                                                              
   Under/normal weight         721            15.4         647       87.8   74    12.2    
   Overweight                  1,342          28.4         1,203     87.4   139   12.6    
   Obese                       2,321          54.2         2,004     84.8   317   15.2    
   Missing                     106            2.1          91        86.9   15    13.1    
  Perceived health                                                                        
   Excellent/very good         1,033          25.3         922       87.8   111   12.2    
   Good                        1,674          39.4         1,480     86.2   194   13.8    
   Fair/poor                   1,783          35.2         1,543     84.7   240   15.3    
  Mental health                                                                           
   Excellent/very good         2,113          49.8         1,867     86.7   246   13.3    
   Good                        1,607          34.9         1,423     86.0   184   14.0    
   Fair/poor                   770            15.3         655       84.3   115   15.7   
  Current smoker                                                                          
   Yes                         666            14.8         601       89.5   65    10.5   ∗∗
   Other                       3,528          78.9         3,076     85.0   452   15.0   
   Missing                     296            6.2          268       91.2   28    8.8    
  Exercise                                                                                
   ≥3 times a week             1,800          41.1         1,618     87.7   182   12.3   ∗
   No exercise                 2,656          58.9         2,298     85.0   358   15.0   
   Missing                     296            6.2          268       91.2   28    8.8    

Based on 4,490 individuals with diabetes, aged 21 years or older and were alive during the calendar years 2007 and 2009.

Asterisks represent significant group differences by the presence of thyroid disorders based on chi-square tests.

\*\*\**P* \< .001; \*\*.001 ≤ *P* \< .01; \*.01 ≤ *P* \< .05.

Please note that the percentages cannot be calculated by dividing the unweighted number by total sample size because the percentages are derived after accounting for the complex survey design of the MEPS.

###### 

Prevalence of co-occurring chronic conditions by the presence of thyroid disorders among individuals with diabetes from the Medical Expenditure Panel Survey, 2007 and 2009.

                                                No thyroid disorders   Thyroid disorders   Sig.                 
  --------------------------------------------- ---------------------- ------------------- --------- ---------- -----
  Any macrovascular comorbid conditions         **1,181**              **30.6**            **213**   **39.5**   ∗∗∗
   Heart disease                                1,061                  28.0                193       35.8       ∗∗
   Stroke                                       225                    5.2                 41        8.0        ∗
   Peripheral vascular disease                  36                     1.0                 6         0.8         
  Any cooccurring physical chronic conditions   **2233**               **58.5**            **414**   **78.9**   ∗∗∗
   Arthritis                                    1635                   41.4                313       55.9       ∗∗∗
   Cancer                                       398                    11.8                91        21.4       ∗∗∗
   Chronic obstructive pulmonary disease        621                    16.3                120       20.5       ∗
   Gastroesophageal reflux disease              497                    13.1                100       17.9       ∗
   Asthma                                       380                    9.3                 77        12.6       ∗
   Anemia                                       140                    3.1                 34        5.9        ∗∗
   Osteoporosis                                 103                    2.8                 33        5.5        ∗∗
   Endocrine disorders                          54                     1.6                 16        3.0         
  Any cooccurring mental health conditions      **929**                **24.9**            **192**   **34.2**   ∗∗∗
   Depression                                   623                    17.2                137       25.1       ∗∗∗
   Anxiety                                      406                    10.6                91        15.7       ∗∗∗
   Schizophrenia                                22                     0.5                 7         0.8         

Based on 4,490 individuals with diabetes, aged 21 years or older and were alive during the calendar years 2007 and 2009.

Asterisks represent significant group differences by the presence of thyroid disorders based on chi-square tests.

\*\*\**P* \< .001; \*\*.001 ≤ *P* \< .01; \*.01 ≤ *P* \< .05.

Please note that the percentages cannot be calculated by dividing the unweighted number by total sample size because the percentages are derived after accounting for the complex survey design of the MEPS.

###### 

Average total and type of expenditures (2009\$) by the presence and absence of thyroid disorders individuals with diabetes from the Medical Expenditure Panel Survey, 2007 and 2009.

                   No thyroid disorders   Thyroid disorders   Unadjusted OLS regression on logged dollars                                                   
  ---------------- ---------------------- ------------------- --------------------------------------------- ------------- ---------- ----------- ---------- -----
  Total            **\$11,093**           **\$382**           **\$15,182**                                  **\$1,055**   **0.50**   **0.006**   **64.4**   ∗∗∗
  Inpatient        3,560                  250                 4,743                                         808           0.49       0.020       63.1       ∗∗∗
  Outpatient       3,118                  188                 4,403                                         487           0.61       0.012       84.2       ∗∗∗
  Prescription     3,214                  87                  4,157                                         239           0.50       0.005       64.7       ∗∗∗
  Emergency room   298                    26                  328                                           74            0.17       0.006       18.6       ∗∗∗
  Other            903                    52                  1552                                          220           0.99       0.024       170.7      ∗∗∗

Based on 4,490 individuals with diabetes, aged 21 years or older and were alive during the calendar years 2007 and 2009.

Asterisks represent significant group differences by the presence of thyroid using ordinary least squares regression log transformed expenditures. Other expenditures included dental, vision, durable medical equipment use, and others.

Percentage expenditures associated with thyroid disorders were estimated by exponentiating the regression coefficients of dummy variables and subtracting one (i.e., percent change = *e* ^*β*^ − 1).

SE: standard error.

\*\*\**P* \< .001; \*\*.001 ≤ *P* \< .01; \*.01 ≤ *P* \< .05.

###### 

Intercept and parameter estimates for the presence of thyroid disorders from ordinary least squares regression on logged healthcare expenditures individuals with diabetes from the Medical Expenditure Panel Survey, 2007 and 2009.

  Thyroid disease     Beta    SE      \% Change   Significance
  ------------------- ------- ------- ----------- --------------
  Total                                            
   Model 1            0.363   0.005   43.8        ∗∗∗
   Model 2            0.295   0.004   34.3        ∗∗∗
   Model 3            0.213   0.005   23.7        ∗∗∗
   Model 4            0.194   0.006   21.4        ∗∗∗
  Inpatient                                        
   Model 1            0.389   0.02    47.6        ∗∗∗
   Model 2            0.299   0.016   34.9        ∗∗∗
   Model 3            0.2     0.017   22.1        ∗∗∗
   Model 4            0.152   0.02    16.4        ∗∗∗
  Emergency room                                   
   Model 1            0.124   0.006   13.2        ∗∗∗
   Model 2            0.089   0.007   9.3         ∗∗∗
   Model 3            0.01    0.006   1.0          
   Model 4            −0.02   0.005   −2.0        ∗∗∗
  Outpatient                                       
   Model 1            0.393   0.011   48.1        ∗∗∗
   Model 2            0.299   0.016   34.9        ∗∗∗
   Model 3            0.208   0.008   23.1        ∗∗∗
   Model 4            0.196   0.009   21.7        ∗∗∗
  Prescription drug                                
   Model 1            0.348   0.009   41.6        ∗∗∗
   Model 2            0.282   0.009   32.6        ∗∗∗
   Model 3            0.193   0.01    21.3        ∗∗∗
   Model 4            0.179   0.01    19.6        ∗∗∗
  Other                                            
   Model 1            0.752   0.03    112.1       ∗∗∗
   Model 2            0.727   0.03    106.9       ∗∗∗
   Model 3            0.646   0.03    90.8        ∗∗∗
   Model 4            0.630   0.03    87.8        ∗∗∗

Based on 4,490 adults with diabetes, aged 21 years or older and were alive during the calendar year 2007 and 2009. Asterisks represent significant group differences by the presence of thyroid disorders using *t*-tests.

Model 1, included age, gender, and race/ethnicity as independent variables. In Model 2, in addition to the variables used in Model 1, other demographic (marital status and metro status), socioeconomic (education, poverty status, and health insurance) health status (perceived physical and mental health) and lifestyle factors (body mass index categories and smoking status) were included. We controlled for number of cooccurring chronic conditions as an additional variable in Model 3., Finally, in Model 4, we also additionally entered presence of any macrovascular comorbid conditions.

\**P* \< .001; \*\*.001 ≤ *P* \< .01; \*.01 ≤ *P* \< .05.

###### 

CCS codes used to identify cooccurring and macrovascular comorbid conditions from the Medical Expenditure Panel Survey, 2007 and 2009.

  Disease category                              Clinical classification code(s)
  --------------------------------------------- ---------------------------------------------
  Diabetes                                      49, 50
  Thyroid disorders                             48
  Any macrovascular comorbid conditions          
   Heart disease                                96, 97, 100 through 108
   Stroke\*                                     342, 430, 431, 432, 434, 435, 436, 437, 438
   Peripheral vascular disease                  114, 248
  Any cooccurring physical chronic conditions    
   Arthritis                                    201, 202, 203, 204
   Cancer                                       11 through 44
   Chronic obstructive pulmonary disease        127
   Gastro esophageal reflux disease             138
   Asthma                                       128
   Anemia\*                                     280 thru 285
   Osteoporosis\*                               206
   Endocrine disorders                          51
  Any cooccurring mental health conditions       
   Depression                                   657
   Anxiety                                      651
   Schizophrenia                                659

\*Indicates used on ICD-9, 3-digit codes instead of CCS codes in defining those conditions.

Details of codes and crosswalk of ICD-9 codes and CCS codes are available on html: <http://meps.ahrq.gov/mepsweb/data_stats/download_data/pufs/h128/h128_icd9codes.shtml>.

[^1]: Academic Editor: C. Marcocci
